RCAG
DRNA

Rehmann Capital Advisory Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Rehmann Capital Advisory Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		$447K Sell
31,125
-30,863
-50% -$443K 0.05% 180
2019
Q2 		$976K Buy
+61,988
New +$976K 0.12% 136